Clinical Trials Browser

Terminated × Lung Neoplasms × camrelizumab × Clear all

NCT03666728 2021-03-17

A Study of SHR-1210 in Combination With BP102 in Subjects With Non-squamous NSCLC

Phase 2 Terminated

Lung Neoplasms